Diana Tran

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Replacement Therapy

Chronic Myeloid Leukemia

Respiratory Tract

Top Venues

Infectious diseases and therapy

PharmacoEconomics - open

Journal of medical economics

Journal of comparative effectiveness research

This page only lists publications with an associated author ORCID identifier.

Publications

Mark H Rozenbaum, Jennifer Toolan Judy, Diana Tran, Kari Yacisin, Samantha K Kurosky, Elizabeth Begier
Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States. Infectious diseases and therapy 12 (2) (2023)
Mark H Rozenbaum, Jennifer Toolan Judy, Diana Tran, Kari Yacisin, Samantha K Kurosky, Elizabeth Begier
Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States. Infectious diseases and therapy (2023)
Jorge E Cortes, Delphine Rea, Michael J Mauro, Diana Tran, Pearl Wang, Kejal Jadhav, Aurore Yocolly, Koji Sasaki
Health care resource utilization in 3L + patients with chronic phase chronic myeloid leukemia receiving asciminib or bosutinib. Journal of medical economics (2023)
Mark H Rozenbaum, Jennifer Toolan Judy, Diana Tran, Kari Yacisin, Samantha K Kurosky, Elizabeth Begier
Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States. Infectious diseases and therapy (2023)
Charlene Lee, Annette Lam, Teresa Kangappaden, Pyper Olver, Sarah Kane, Diana Tran, Eric M Ammann
Systematic literature review of evidence in amyloid light-chain amyloidosis. Journal of comparative effectiveness research 11 (6) (2022)
Massimiliano Bonifacio, Vikalp Maheshwari, Diana Tran, Gianluca Agostoni, Kalitsa Filioussi, Ricardo Viana
Economic Model to Evaluate the Cost-Effectiveness of Second-Line Nilotinib Versus Dasatinib for the Treatment of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (CML-CP) in Italy. PharmacoEconomics - open (2021)